Omega Healthcare Investors, Inc. – Consensus ‘buy’ rating and 5.6% Upside Potential

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

Omega Healthcare Investors, Inc. which can be found using ticker (OHI) have now 15 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $49.00 and $35.00 with the average target price sitting at $42.27. Given that the stocks previous close was at $40.03 and the analysts are correct then there would likely be a percentage uptick in value of 5.6%. There is a 50 day moving average of $40.65 and the 200 day MA is $34.99. The company has a market capitalization of 11.10B. The stock price is currently at: $39.51 USD

The potential market cap would be $11,724,150,988 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 29.05, revenue per share of $4.03 and a 3.9% return on assets.

Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through the segment, which consists of investments in healthcare-related real estate properties located in the United States and the United Kingdom. The Company’s core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). The Company’s portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. Its portfolio of real estate investments includes over 926 healthcare facilities, located in 42 states and the United Kingdom that are operated by 67 third-party operators.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search